Jiangsu Delfu Medical Devices Co., Ltd

Years

Shop

Shop
All

Favorites

You are here: Home > Suppliers > Jiangsu Delfu Medical Devices Co., Ltd > Company Profile

Basic Information

Company Name

Jiangsu Delfu Medical Devices Co., Ltd

Year of Establishment

2010

Enterprise Size

100-500

Annual Turnover（USD）

500,000 to 99,999,999

Company Introduction

Jiangsu Delfu Medical Devices Co., LTD., officially established in May 2010, is one of the wholly-owned subsidiaries of Jiangsu Huayang Intelligent Equipment Co., LTD., with more than 15 years of industry experience in the field of precision drug delivery. The company is mainly engaged in the design, production, sales and service of mechanical pen injector, electronic pen injector, Internet of Things intelligent electronic pen injector, micro injection pump related products. At the beginning of the company to provide customers with every product into the "Delfu" team "Dedicated, Professional, Confident, Insistent, Concerted, Cohesive" dedication quality and professional standards. And fully understand the wishes and needs of customers, adhering to the parent company's core concept of "quality achievement development, innovation to create the future", after nearly 13 years of precipitation: In terms of technological innovation, we have been recognized as a high-tech enterprise, a municipal high-tech product and two municipal engineering technology research centers. We have also obtained more than 50 independent patents, including more than 7 invention patents, 1 German patent and 5 computer software Copyrights. In terms of quality control management, our ISO13485 system has obtained TUV certification approval, a number of pen syringes have obtained the registration certificate of medical devices, and some products have obtained the EU CE certification, which guarantees the value of "Delfu" products; In terms of products, we have formed 5 product platforms, 14 types of basic products, and have formed cooperation with more than 20 pharmaceutical factories at home and abroad. Successfully used in 9 diseases (diabetes, osteoporosis, short stature, infertility, Parkinson, etc.) 14 drugs (insulin, GLP1, growth hormone, teriparatide, follicle stimulating hormone, etc.) microprecise drug delivery subcutaneous injection treatment. Different groups, different drugs have different needs for micro-precision drug delivery devices, "Delfu" series of products is the spirit of "to provide patients with high quality, affordable injection devices; To provide precise drug delivery solutions for pharmaceutical enterprises; The product concept of "Providing health management equipment for high-end demand groups" is designed in combination with the administration characteristics of different drugs and the characteristics of different drug groups. We do not let go of every detail in the production process, strict control, with the best and most rigorous design scheme and manufacturing means, so that every drop of liquid medicine can play its due value......

Main Competitive Advantages

Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,

Postal Code

213000

Website

http://www.jsdelfu.com/

Other Competitive Advantages

In terms of products, we have formed 5 product platforms, 14 types of basic products, and have formed cooperation with more than 20 pharmaceutical factories at home and abroad. Successfully used in 9 diseases (diabetes, osteoporosis, short stature, infertility, Parkinson, etc.) 14 drugs (insulin, GLP1, growth hormone, teriparatide, follicle stimulating hormone, etc.) microprecise drug delivery subcutaneous injection treatment. Different groups, different drugs have different needs for micro-precision drug delivery devices, "Delfu" series of products is the spirit of "to provide patients with high quality, affordable injection devices; To provide precise drug delivery solutions for pharmaceutical enterprises; The product concept of "Providing health management equipment for high-end demand groups" is designed in combination with the administration characteristics of different drugs and the characteristics of different drug groups. We do not let go of every detail in the production process, strict control, with the best and most rigorous design scheme and manufacturing means, so that every drop of liquid medicine can play its due value......

Patents and Copyright

In terms of technological innovation, Delfu have been recognized as a high-tech enterprise, a municipal high-tech product and two municipal engineering technology research centers. We have also obtained more than 50 independent patents, including more than 7 invention patents, 1 German patent and 5 computer software Copyrights.

Milestone

Brand start-up (2010) : Delfu was founded in 2010, the company cooperated with Huazhong University of Science and Technology, Nanjing University and overseas professional technical teams, and invested more than 100 million yuan into the field of medical devices. Rising period (2010-2015) : Delfu has built four product solution platforms, namely differential mechanical structural injection, direct thrust mechanical structural injection, trigger automatic injection and electronic intelligent injection, to provide precise drug delivery solutions for pharmaceutical enterprises. Stable maturity period (2015-2018) : The company has passed the ISO 13485 certification of TUV company. A number of products have completed clinical trials, CE certification, CFDA certification, and obtained more than 50 patents. The products have been successfully used in the micro-precision injection of insulin, GLP1, growth hormone, follicle stimulating hormone and other monoclonal antibody, peptide, protein biological agents. Continuous innovation period (2018 till now) : For more than 10 years, Delfu has been focusing on the deep cultivation in the field of micro-drug delivery. Based on the four product solution platforms, Delfu has added the electronic IOT wearable drug delivery platform, developed micro-intelligent injection pump, dual-track intelligent syringe and other products, and provided health management equipment for high-end demand groups.